Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol Plus EVL for Primary Prevention of Esophageal Variceal Bleeding
NCT06594783Phase 4Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jan 2025
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in esophageal varices, Cirrhosis, sponsored by Taipei Veterans General Hospital. Started Jan 2025; status: recruiting.
02
Drugs
carvedilol
03
Conditions
esophageal varicesCirrhosis
Beyond the preview
Go deeper on NCT06594783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594783.